The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 18, 2023
Filed:
Dec. 18, 2020
Applicant:
The Procter & Gamble Company, Cincinnati, OH (US);
Inventors:
Jeanette Anthea Richards, Liberty Township, OH (US);
James Robert Schwartz, West Chester, OH (US);
Leo Timothy Laughlin, II, Mason, OH (US);
Geoffrey Marc Wise, Reading, OH (US);
Eric Scott Johnson, Hamilton, OH (US);
Assignee:
The Procter & Gamble Company, Cincinnati, OH (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61Q 5/12 (2006.01); A61K 8/368 (2006.01); A61K 8/49 (2006.01); A61K 8/34 (2006.01); A61K 8/365 (2006.01); A61K 8/41 (2006.01); A61K 8/42 (2006.01); A61K 8/44 (2006.01); A61K 8/46 (2006.01); A61K 8/60 (2006.01); A61K 8/67 (2006.01); A61K 8/73 (2006.01); A61K 8/81 (2006.01); A61K 8/86 (2006.01); A61K 8/891 (2006.01); A61K 8/892 (2006.01); A61K 8/92 (2006.01); A61Q 5/02 (2006.01);
U.S. Cl.
CPC ...
A61K 8/368 (2013.01); A61K 8/34 (2013.01); A61K 8/342 (2013.01); A61K 8/345 (2013.01); A61K 8/347 (2013.01); A61K 8/365 (2013.01); A61K 8/416 (2013.01); A61K 8/42 (2013.01); A61K 8/44 (2013.01); A61K 8/463 (2013.01); A61K 8/4926 (2013.01); A61K 8/4953 (2013.01); A61K 8/602 (2013.01); A61K 8/675 (2013.01); A61K 8/731 (2013.01); A61K 8/732 (2013.01); A61K 8/8176 (2013.01); A61K 8/86 (2013.01); A61K 8/891 (2013.01); A61K 8/892 (2013.01); A61K 8/922 (2013.01); A61Q 5/02 (2013.01); A61Q 5/12 (2013.01);
Abstract
The present invention is directed to a personal composition comprising a) a strobilurin; b) salicylic acid wherein the ratio of a:b is from about 1:1 to about 100:1; wherein there is a synergistic anti-inflammatory/cellular stress activity.